Transcriptomics

Dataset Information

0

Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis [Lpcat3_OE]


ABSTRACT: Nonalcoholic steatohepatitis (NASH), characterized by inflammation and fibrosis, is emerging as a leading etiology of hepatocellular carcinoma (HCC). However, the mechanisms underlying the pathogenesis of NASH are not well understood. Here, we show that membrane phospholipid (PL) composition determined by a remodeling process modulates the progression of NASH. The expression of lysophosphatidylcholine acyltransferase 3 (LPCAT3), a PL remodeling enzyme that produces polyunsaturated PLs, is dramatically suppressed in human NASH livers compared to controls. LPCAT3 expression is inversely correlated with NAFLD activity score and fibrosis stage. Loss of Lpcat3 in mouse liver promotes the development of both spontaneous and diet-induced NASH/HCC. Mechanistically, Lpcat3 deficiency increases reactive oxygen species production, likely due to impaired mitochondrial homeostasis as demonstrated by reduced mitochondrial DNA content and fragmented mitochondrial morphology. Overexpressing Lpcat3 in the liver ameliorates inflammation and fibrosis of NASH. These results suggest that manipulating LPCAT3 expression may be an effective therapeutic strategy for NASH.

ORGANISM(S): Mus musculus

PROVIDER: GSE218074 | GEO | 2024/06/05

REPOSITORIES: GEO

Similar Datasets

2024-06-05 | GSE218073 | GEO
2024-06-05 | GSE218075 | GEO
2024-06-05 | GSE268838 | GEO
2015-06-26 | E-GEOD-65352 | biostudies-arrayexpress
2015-06-26 | E-GEOD-65353 | biostudies-arrayexpress
2023-04-25 | PXD037737 | Pride
2022-06-02 | E-MTAB-9973 | biostudies-arrayexpress
2015-06-26 | GSE65353 | GEO
2015-06-26 | GSE65352 | GEO
2021-08-19 | MSV000088003 | MassIVE